CJC-1295 + Ipamorelin 10mg
£34.99 per vial · Peptide blends · Research use only
Available to order. Dispatch delayed while we await restock. We will email you with an update; a dispatch date is not yet confirmed. If you would rather not wait, reply to your confirmation email to cancel before dispatch for a full refund.
About CJC-1295 + Ipamorelin 10mg
CJC-1295 + Ipamorelin 10mg is a blend of CJC-1295 without DAC and Ipamorelin, supplied as lyophilised powder in a single vial for in-vitro laboratory research.
Product specifications
- Compound
- CJC-1295 + Ipamorelin
- Declared content
- 10mg per vial
- Format
- Lyophilised powder
Declared blend composition per vial: CJC-1295 (no DAC) 5mg; Ipamorelin 5mg.
Batch documentation
The current published lot is IP-CJI10-001. The batch record from Janoshik Analytical (CZ), dated 24 August 2026, lists reported purity of 99.798% (RP-HPLC) and measured content of 10.45 mg/vial.
View the certificate of analysis →
Intended use
For in-vitro laboratory research only. Not for human or veterinary use.
Technical notes and further reading
Specification
| SKU | CJI10 |
|---|---|
| Compound | CJC-1295 + Ipamorelin |
| Price | £34.99 per vial |
| Format | 10mg per vial |
| Availability | Backorder — dispatch delayed |
| Declared composition | CJC-1295 (no DAC) 5mg + Ipamorelin 5mg |
| Component: CJC-1295 (no DAC), 5mg | CAS 863288-34-0 · C152H252N44O42 · MW 3367.9 g/mol |
| Component: Ipamorelin, 5mg | CAS 170851-70-4 · C38H49N9O5 · MW 711.9 g/mol |
| Published batch / lot | IP-CJI10-001 |
| Reported purity | 99.798% (RP-HPLC) |
| Measured content | 10.45 mg/vial |
| Identity status | LC-MS identity result not published |
| Tested by | Janoshik Analytical (CZ) |
| Report date | 2026-08-24 |
| Storage | Lyophilised: −20 °C, protect from light |
| Certificate of analysis | Published for lot IP-CJI10-001 — download it from this page, or request a copy |
| Intended use | In-vitro laboratory research only |
CJC-1295 + Ipamorelin 10mg blend: UK buying checks
This blend declares 5mg CJC-1295 without DAC and 5mg Ipamorelin per vial, giving a combined 10mg fill. Compare each component amount and the no-DAC specification when sourcing CJC-1295 Ipamorelin blends in the UK. The 2mg CJC-1295 DAC product is a different listing. Review the available batch documentation and dispatch notice for this blend before ordering.
- Ipamorelin 5mg — Compare the current price, availability and batch record.
What does the research on CJC-1295 + Ipamorelin investigate?
This is a two-component blend: CJC-1295 without the Drug Affinity Complex, paired with ipamorelin, five milligrams of each in a single vial. The absence of the DAC matters analytically. Without the maleimide, the first component has no thiol reactivity, so the mixture does not carry a group that will conjugate or hydrolyse on storage, which makes it a considerably more straightforward material to keep and to analyse than the DAC-bearing version. The second component, ipamorelin, is a pentapeptide containing no cysteine, methionine or tryptophan, so it has no oxidation liability either. What remains is the general difficulty of measuring a blend: two peptides of differing hydrophobicity that must be separated before either can be quantified, and a certificate that has to state the ratio between them rather than one purity figure. This page describes the material and its documentation only.
Who can buy CJC-1295 + Ipamorelin?
CJC-1295 + Ipamorelin is supplied strictly as a research chemical for in-vitro laboratory research. Products are sold exclusively to qualified researchers and licensed laboratories.
At checkout the buyer confirms that they are 18 or over, are buying in the course of research, and are responsible for handling, storing and disposing of the material in line with their laboratory's procedures. CJC-1295 + Ipamorelin is not for human or veterinary use.
We only answer questions about specifications, documentation and orders.
How are identity and quality assured?
Each released lot is tested and the result is published, rather than the material being described as high purity on the strength of a supplier's word. Purity is measured by reversed-phase HPLC at an independent laboratory. The laboratory used for every lot published so far is Janoshik Analytical, in the Czech Republic, and the result is stated alongside the measured content against label so the two can be read together.
The report carries the lot number printed on the vial, which is the part that matters. A certificate showing a result without a lot number cannot be tied to the vial in front of you, and a certificate for a different lot tells you nothing about yours. Matching the printed number on the label to the number on the report is a five second check and it is the whole point of publishing both.
Identity confirmation by mass spectrometry is a separate test and is ordered as an add-on, so the figures published here come from RP-HPLC purity testing unless a report says otherwise. Where no report is published for a listing yet, the documentation held for the lot being shipped can be requested before you order. We would rather send you what exists than let you assume a certificate is available when it is not.
Synthesis and supply
Peptide material is built by solid-phase synthesis, purified by preparative HPLC, then lyophilised. Lyophilisation freezes the solution and removes the solvent under vacuum, which is why the vial arrives holding a cake or powder rather than a liquid and why a solvent has to be added before the material can be worked with. Removing water also removes the main route by which a peptide degrades in storage, which is the reason the format is used.
Sequence length and modification are what make batches differ in difficulty. Every coupling step is an opportunity for a truncated or deleted by-product, and a heavily modified or long chain presents more of them, which is why the purity trace rather than the headline figure is what a certificate is read for. Vials are filled and labelled with the lot number, and the lot number is what the report and the verification lookup resolve against.
Two separately synthesised and purified peptides meeting in one fill means the analytical burden is the combination of both compounds plus the ratio between them.
External resources for researchers
These are the public reference sources we use when checking the identity of CJC-1295 + Ipamorelin, and the ones worth going to before relying on anything stated on a product page, including this one.
- PubChem — Compound records, computed properties, depositor-supplied identity data.
- CAS Common Chemistry — CAS Registry lookups where a registry number is known.
- ChEBI — Curated chemical ontology entries with cross-references.
- Europe PMC — Primary literature search by compound name, sequence or registry number.
- Certificate hub — Reports published for the lots released so far.
Frequently asked questions
Which CJC-1295 is in the blend — with or without DAC?
Without DAC. The blend uses modified GRF(1–29), the 29-residue chain with no maleimidopropionyl lysine attached. The DAC form is listed separately as CJD2 and is a different compound with its own registry number and a higher mass.
Is the 5mg to 5mg split equimolar?
No. The components are matched by mass, and their molecular weights differ by roughly a factor of five, so ipamorelin contributes around five times as many molecules as the CJC-1295 component. A molar calculation has to be done component by component.
What does the blend contain?
Two distinct peptides co-formulated in one vial: a modified GRF(1–29) chain without DAC, and ipamorelin. Each keeps its own identity, and the batch record reports each component separately. Index Peptides supplies the blend as a research material and makes no claim about any application of it.
Is CJC-1295 + Ipamorelin supplied for human or veterinary use?
No. CJC-1295 + Ipamorelin is supplied as a lyophilised powder in a sealed vial and is supplied strictly as a research chemical for in-vitro laboratory research. Products are sold exclusively to qualified researchers and licensed laboratories, and buyers confirm they are 18 or over and purchasing in the course of research. We only answer questions about specifications, documentation and orders.
The label on a blend states a total weight, not a per-component weight. How should that be read?
A blend figure is an arithmetic total of the components weighed separately, so a vial labelled 20mg of a two-component blend contains 10mg of each rather than 20mg of each. The declared split per vial is stated on this page and in the specification table. That matters for any molar or concentration calculation: work from the per-component figure, not the label total.
How is the purity figure measured, and what does it actually tell me?
Purity is measured by reversed-phase HPLC at an independent laboratory, and the result is published with the method conditions rather than as a bare percentage. The figure is the proportion of the UV-absorbing material in the chromatogram that elutes as the target peak. It describes the sample as analysed; it is not a statement about what the material is for. A high figure alongside a clean chromatogram is the useful combination, which is why the report is worth reading rather than the headline number alone.
What documentation comes with a batch?
Each released lot carries a number printed on the vial label and a report stating purity by RP-HPLC, measured content against label, and the testing laboratory. Reports published so far are listed on this page and collected on the certificate hub, and each carries a lot number that can be checked against the vial in front of you. Where a report is not yet published for a listing, ask before ordering and we will send the documentation that exists for the lot being shipped.
How should CJC-1295 + Ipamorelin be stored?
In the form supplied, as a lyophilised powder, the material is stable kept cold, dry and dark. For powder, that means a freezer at around minus 20 degrees Celsius, desiccated, with the vial sealed and shielded from light, which is how it should stay until you are ready to work with it. Bringing a vial to room temperature before opening avoids condensation on the contents. Once in solution the material is less stable than the powder and should be kept cold and used within a short working window. Choosing a solvent and storage conditions for your own work is your call, not ours.
Do I need bacteriostatic water to prepare it?
A lyophilised powder needs a solvent added before it can be worked with. Bacteriostatic water, which is water with 0.9% benzyl alcohol, is the common choice because the preservative extends the working life of the solution once the vial has been opened, and we supply it in 3ml and 10ml vials. It is not the only option: where a method cannot tolerate benzyl alcohol, use the solvent the method specifies. The choice affects the sample, so it belongs to the researcher.
How and when is an order shipped?
Orders are dispatched from the United Kingdom. An order placed before 4pm on a working day is collected the same day; weekends and bank holidays roll forward to the next working day. Delivery is tracked, and shipping is free on UK orders over 30 pounds, with tracked 48 hour service at 3.65 pounds below that. Tracking is sent when the parcel is collected, so the first scan is usually visible the same evening.
Why does this blend omit the DAC that CJC-1295 sometimes carries?
Because the DAC is a reactive maleimide that conjugates to thiols and hydrolyses slowly in water. Leaving it out removes that reactivity, so the blend has no group that is steadily losing activity on the shelf. The trade-off is that the molecule no longer has a covalent attachment route to a carrier protein. Which version suits a piece of work depends on the question being asked, and that is a research decision rather than a supplier recommendation.
How is a two-component blend tested?
Each component has to be resolved from the other before it can be measured, then the ratio between them quantified alongside the overall purity of the lot. Two peptides of similar hydrophobicity can elute close together, which would make them read as a single peak and overstate both. That usually requires a method developed for this specific pair rather than a general gradient.
Is five milligrams of each component the same as ten milligrams of material?
The vial contains ten milligrams in total, but that is an arithmetic sum and not a statement about either component. A draw from the vial delivers a share of each rather than five milligrams of each in full, and any molar calculation should be done per component from its own molecular weight. Using the label total will overstate both.
What is worth checking before relying on a blend lot?
That the certificate states per-component identity and the ratio between the components, alongside the overall purity of the lot, and that the lot number matches the vial. A single purity percentage for a two-component blend tells you little on its own, because it does not say which peak produced it or in what proportion.
Documentation & batch verification
The current released lot is IP-CJI10-001, tested 2026-08-24 by Janoshik Analytical (CZ): RP-HPLC purity 99.798% (RP-HPLC), measured content 10.45 mg/vial, identity Purity confirmed (RP-HPLC). The full report for this lot is published and can be checked online — verify this batch. See the full record for lot IP-CJI10-001 or all published certificates of analysis.
Published batch records show the laboratory, report date, purity and measured content where reported. Check the certificate for the exact lot: an HPLC purity result does not establish LC-MS identity, sterility or suitability for human or animal use. Review the published batch record before ordering.
Order CJC-1295 + Ipamorelin 10mg online — UK dispatch · Request an invoice · Verify a batch
Research use only. Not for human or animal consumption.